Dietmaier, W. ; Lorenz, J. ; Riemenschneider, M.J.
Alternative Links zum Volltext:DOIVerlag
| Dokumentenart: | Artikel |
|---|
| Titel eines Journals oder einer Zeitschrift: | Der Pathologe |
|---|
| Verlag: | SPRINGER |
|---|
| Ort der Veröffentlichung: | NEW YORK |
|---|
| Band: | 36 |
|---|
| Nummer des Zeitschriftenheftes oder des Kapitels: | 2 |
|---|
| Seitenbereich: | S. 171-180 |
|---|
| Datum: | 2015 |
|---|
| Institutionen: | Medizin > Abteilung für Neuropathologie
Medizin > Lehrstuhl für Pathologie |
|---|
| Identifikationsnummer: | | Wert | Typ |
|---|
| 10.1007/s00292-015-0002-6 | DOI |
|
|---|
| Stichwörter / Keywords: | MGMT PROMOTER METHYLATION; PILOCYTIC ASTROCYTOMAS; ANAPLASTIC GLIOMAS; PHASE-3 TRIAL; IDH1 MUTATION; GLIOBLASTOMA; TEMOZOLOMIDE; MEDULLOBLASTOMA; RADIOTHERAPY; AMPLIFICATION; Glioma; MGMT; 1p/19q; IDH1/2; Pediatric brain tumors |
|---|
| Dewey-Dezimal-Klassifikation: | Nicht ausgewählt |
|---|
| Status: | Veröffentlicht |
|---|
| Begutachtet: | Ja, diese Version wurde begutachtet |
|---|
| An der Universität Regensburg entstanden: | Ja |
|---|
| Dokumenten-ID: | 60585 |
|---|
Web of Science
Zusammenfassung
As in only few other areas of oncology, molecular markers in neurooncology have become an integral part of clinical decision-making. This development is driven by a bustling scientific activity exploring the molecular basis and pathogenesis of human brain tumors. In addition, a high percentage of brain tumor patients are included in clinical studies in which molecular markers are assessed and ...
Zusammenfassung
As in only few other areas of oncology, molecular markers in neurooncology have become an integral part of clinical decision-making. This development is driven by a bustling scientific activity exploring the molecular basis and pathogenesis of human brain tumors. In addition, a high percentage of brain tumor patients are included in clinical studies in which molecular markers are assessed and linked with clinical informativeness. First steps towards more differentiated therapeutic strategies against brain tumors have thus been taken. The implementation in the clinical and diagnostic routine requires a detailed knowledge and a close collaboration between all medical disciplines involved.
Altmetric